NEXGEL Secures $950,000 in Direct Offering for Growth
NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL), a prominent player in the healthcare sector renowned for its innovative ultra-gentle, high-water-content hydrogels, has today announced a noteworthy registered direct offering alongside a concurrent private placement that is set to significantly enhance its financial footing. The Company is issuing 413,044 shares of its common stock at a price of $2.30 per share.
Financial Highlights of the Offering
This substantial offering not only embodies the confidence in NEXGEL's growth trajectory but also the strategic planning that governs its financial strategies. Alongside the registered offering, NEXGEL has introduced unregistered warrants allowing investors the opportunity to buy an additional 206,522 shares at an exercise price of $4.25 per share. These warrants are immediately exercisable and extend for a period of five years.
CEO's Perspective on Growth
Adam Levy, the CEO of NEXGEL, expressed optimism regarding the company's financial maneuvers. Levy remarked that this financing, in combination with their existing cash reserves and a recent $1 million non-dilutive advance, fortifies the Company’s balance sheet. He believes this capital boost will provide the necessary working capital as NEXGEL anticipates a period of significant growth approaching.
Agent Partnership and Future Plans
Alere Financial Partners, LLC, a division of Cova Capital Partners, served as the exclusive placement agent managing this offering. The contributions from such tailored partnerships are crucial in navigating financial markets effectively.
Understanding the Registration Process
The shares being offered in the registered direct offering are linked to the Company’s established shelf registration statement on Form S-3 which received SEC approval. The transparency provided by this process reassures investors regarding the legitimacy and governance of the offering.
About NEXGEL, Inc.
NEXGEL stands out as a leader in the creation of innovative healthcare, beauty, and over-the-counter (OTC) products with its hallmark high-water-content hydrogels. With a solid base in development and manufacturing lasting over two decades, NEXGEL’s brands like Silverseal, Hexagels, Turfguard, and Kenkoderm consistently push industry standards. The Company’s collaborative manufacturing efforts with top consumer healthcare partners further solidify its reputation in the market.
Frequently Asked Questions
What is the significance of NEXGEL's $950,000 offering?
This offering is meant to strengthen the Company’s financial position and provide essential working capital as they aim for growth.
How does Adam Levy view this financial move?
He expresses that the financing, along with previous advances, enhances the Company's balance sheet and positions NEXGEL for sustained growth.
Who acted as the placement agent for this offering?
Alere Financial Partners, LLC managed the offering as the exclusive placement agent.
What types of warrants are included in the offering?
The offering includes unregistered warrants for investors to purchase additional shares at a specified price, adding potential value for participants.
Where can I find more information about NEXGEL?
NEXGEL provides detailed prospectus documents available at the SEC’s website for investors seeking to learn more about the Company and its offerings.
